Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Redwood Pharma AB
DescriptionTopical eye treatment based on a naturally occurring endogenous molecule using Broda's IntelliGel supramolecular hydrogel technology
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationDry eye
Indication DetailsTreat chronic dry eye syndrome
Regulatory Designation
PartnerBroda Technologies Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today